Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer 02-20-2019 mediabest Health News TUESDAY, Feb. 19, 2019 — The multigene expression test Oncotype Read more
Negligible drop in neoplastic lesion Dx after first round of FIT 10-03-2018 mediabest Health Problems (HealthDay)—After the first round of a fecal immunochemical test (FIT)-based, Read more